Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment (Q33873657)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment (English)

1 reference

Europe PubMed Central

29 July 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

8

object named as

Paul P Tak

1 reference

Europe PubMed Central

29 July 2017

author name string

Lisa Gm van Baarsen

1

1 reference

Europe PubMed Central

29 July 2017

Carla A Wijbrandts

2

1 reference

Europe PubMed Central

29 July 2017

François Rustenburg

3

1 reference

Europe PubMed Central

29 July 2017

Tineke Cantaert

4

1 reference

Europe PubMed Central

29 July 2017

Tineke Ctm van der Pouw Kraan

5

1 reference

Europe PubMed Central

29 July 2017

Dominique L Baeten

6

1 reference

Europe PubMed Central

29 July 2017

Ben Ac Dijkmans

7

1 reference

Europe PubMed Central

29 July 2017

Cornelis L Verweij

9

1 reference

Europe PubMed Central

29 July 2017

publication date

22 January 2010

1 reference

Europe PubMed Central

29 July 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

29 July 2017

12

1 reference

Europe PubMed Central

29 July 2017

R11

1 reference

Europe PubMed Central

29 July 2017

1

1 reference

Europe PubMed Central

29 July 2017

https://scigraph.springernature.com/pub.10.1186/ar2912

0 references

Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

The Stanford Microarray Database: implementation of new analysis tools and open source release of software

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

The Disease Activity Score and the EULAR response criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

The emerging role of interferon in human systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Autoimmunity through cytokine-induced dendritic cell activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

5 July 2018

Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

29 October 2018

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

29 October 2018

Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

29 October 2018

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

29 October 2018

Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875639

29 October 2018

Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray

1 reference

https://pubmed.ncbi.nlm.nih.gov/20096109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20096109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of rheumatoid arthritis improvement criteria that include simplified joint counts

1 reference

https://pubmed.ncbi.nlm.nih.gov/20096109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A subtype of multiple sclerosis defined by an activated immune defense program

1 reference

https://pubmed.ncbi.nlm.nih.gov/20096109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression profiling in rheumatology

1 reference

https://pubmed.ncbi.nlm.nih.gov/20096109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon–response genes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20096109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20096109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arthritogenic dsRNA is present in synovial fluid from rheumatoid arthritis patients with an erosive disease course

1 reference

https://pubmed.ncbi.nlm.nih.gov/20096109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

29 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33873657&oldid=1635744402"